Another ADHD meds shortage


The TGA has warned of shortages of Concerta and Methylphenidate-Teva XR modified-release methylphenidate hydrochloride tablet products The Therapeutic Goods Administration says that Janssen-Cilag has notified it about current expected shortages of Concerta, while Teva Pharma Australia is expecting the shortage of its modified-release methylphenidate hydrochloride tablets to be resolved by mid-December. “We acknowledge the concerns

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Renowned pharmacist’s act, and new Pharmacy Acts
Next Children common in opioid toxicity hospitalisations